Cargando…
A Case Report on Metamizole-Induced Agranulocytosis: Is the Benefit Worth the Risk?
Metamizole is a drug with analgesic and antipyretic properties widely available in Portugal. Its use is highly controversial because of the risk of agranulocytosis, a rare but serious adverse event. A 70-year-old female patient with a recent history of treatment with metamizole for post-surgery feve...
Autores principales: | Carvalho, Rita, Henriques, Célia, Fernandes, Marco, Gouveia, Cláudio, Gama, Catarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981226/ https://www.ncbi.nlm.nih.gov/pubmed/36874711 http://dx.doi.org/10.7759/cureus.34467 |
Ejemplares similares
-
The involvement of specific t cells in the pathogenesis of metamizole-induced agranulocytosis
por: Adam, Jacqueline, et al.
Publicado: (2014) -
Metamizole-induced agranulocytosis (MIA): a mini review
por: Tomidis Chatzimanouil, Markos K., et al.
Publicado: (2023) -
Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
por: Munir, Farrukh, et al.
Publicado: (2022) -
Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
por: Cismaru, Anca Liliana, et al.
Publicado: (2020) -
Fungal Periprosthetic Knee Joint Infection in a Patient with Metamizole-Induced Agranulocytosis
por: Oenning, Sebastian, et al.
Publicado: (2020)